Reference : Interet et limites du depistage de masse du cancer du sein par mammographie seule (mammo...
Scientific journals : Article
Human health sciences : Reproductive medicine (gynecology, andrology, obstetrics)
http://hdl.handle.net/2268/24652
Interet et limites du depistage de masse du cancer du sein par mammographie seule (mammotest)
French
[en] Benefits and Limitations of Mammography
Lifrange, Eric mailto [Centre Hospitalier Universitaire de Liège - CHU > > Sénologie >]
Bleret, Valerie [Centre Hospitalier Universitaire de Liège - CHU > > Sénologie >]
Desreux, Joëlle mailto [Centre Hospitalier Universitaire de Liège - CHU > > Sénologie >]
Dondelinger, Robert mailto [Université de Liège - ULg > Département des sciences cliniques > Radiologie - Imagerie médicale >]
Foidart, Jean-Michel mailto [Université de Liège - ULg > Département des sciences cliniques > Gynécologie - Obstétrique >]
Gaspard, Ulysse mailto [Université de Liège - ULg > Services généraux (Faculté de médecine) > Relations académiques et scientifiques (Médecine)]
Herman, Philippe mailto [Centre Hospitalier Universitaire de Liège - CHU > > Sénologie - Gynécologie-Obstétrique >]
Van Cauwenberge, Jean-Rémy mailto [Université de Liège - ULg > Département des sciences cliniques > Gynécologie-Obstétrique-Sénologie >]
Colin, Claude [Université de Liège - ULg > > Gynécologie - Obstétrique >]
May-2003
Revue Médicale de Liège
Hopital de Baviere
58
5
331-7
Yes (verified by ORBi)
0370-629X
Liège
Belgique
[en] Breast neoplasms ; Diagnosis ; Breast radiography ; Cancer screening
[en] The literature on screening mammography provides ample opportunity for doubt (the sceptics) and dogma (the screening zealots), and can be interpreted to prove both benefit and harm. The benefit of mammography screening, if any, is modest and the balance between beneficial (potentially, a 20% relative reduction in breast cancer mortality with no significant benefit on all-cause mortality) and harmful (physical and psychological morbidity related to the 15-40% missed cancers and the 80-90% false-positive diagnoses) effects is still delicate. The mammogram alone is a modest weapon. Concurrent clinical breast examination is mandatory. Women that are concerned about breast cancer should be fully informed of the potential benefits and risks of screening mammography. These women should benefit from mammography with concurrent clinical breast examination, and possible whole-breast ultrasound in heterogeneously dense and extremely dense breast patterns.
http://hdl.handle.net/2268/24652

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Lifrange F 2003.pdfPublisher postprint450.4 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.